Vaccination Data At A Glance
All data presented on this page, except where otherwise noted, are available through the Chicago Data Portal. For more detailed data related to COVID-19 vaccinations, including data by ZIP Code, see the COVID-19 Dashboard. For information related to COVID-19 cases and testing, see the Coronavirus At A Glance and COVID-19 Dashboard.
COVID-19 vaccinations among Chicago residents
Initial vaccine rollout focused on those aged 65 and older and essential workers. These groups are considered to be the most at-risk of COVID-19 infection and/or severe outcomes. Over time those eligible has expanded, and all Chicagoans 12+ are now eligible for vaccination.
Vaccination coverage percentages are not calculated for race-ethnicity groups with small populations in Chicago. Differences in how race-ethnicity data are collected on vaccination forms and the U.S. Census may result in over or under estimates of coverage in these groups. All data are provisional and subject to change.
Doses given to Chicago residents
There are currently three vaccines that are available to Chicago residents-Pfizer, Moderna, and Johnson & Johnson (also called Janssen). Pfizer and Moderna require two doses, while Johnson & Johnson requires one dose. This graph shows the 7-day rolling average number of Chicago residents who have received at least one dose of vaccine or have completed a vaccine series. A rolling average smooths out day-to-day jumps, but still provides current information about vaccine administration.
Chicago residents with at least one dose of vaccine
This graph shows the percentages of Chicago residents who have received at least one dose of any COVID-19 vaccine over time. This includes people who have received at least one dose of a two-dose vaccine or a single dose of a one-dose vaccine.
Chicago residents who have completed a vaccine series
This graph shows the percentages of Chicago residents who have received all doses required to be considered fully vaccinated over time. This means that they have had both doses of a two-dose vaccine or a single dose of a one-dose vaccine.
Under Protect Chicago, vaccination reports will reflect Chicago demographics/look like Chicago.
- 59% of Chicagoans are Black or Latinx*.
- Yet in the first week of COVID vaccination in Chicago, when vaccine was only available to health care workers and all vaccine eligibility was linked to employment status, only 18% of COVID vaccines went to Black or Latinx Chicagoans.
- In more recent weeks of COVID vaccination in Chicago, with vaccine available to people 65+ and front-line essential workers, community partners building vaccine confidence and access, and our Protect Chicago equity-driven distribution strategy in place, the make-up of those who have received a first dose is more reflective of the demographic make-up of Chicago*.
- We still have a long way to go to achieve equity, but our city’s Protect Chicago initiatives are yielding real improvements. Track our progress in the chart below.
*Chicago demographics: 32.9% White, non-Latinx; 29.8% Black, non-Latinx; 29.0% Latinx; 6.7% Asian, non-Latinx
AI/AN = American Indian/Alaska Native, PI/NH = Pacific Islander/Native Hawaiian
Data reported through 6/30/21. Percentage calculated among those with known race ethnicity. Due to a change in how ‘Other race’ is being captured in I-CARE, ‘Other, non-Latinx’ is no longer being displayed on this graphic; instead, AI/AN and PI/NH are shown.
- Data as of June 30, 2021
- Data as of June 23, 2021
- Data as of June 14, 2021
- Data as of June 7, 2021
- Data as of May 31, 2021
- Data as of May 11, 2021
- Data as of April 26, 2021
- Data as of April 12, 2021
- Data as of April 6, 2021
- Data as of March 30, 2021
- Data as of March 17, 2021
- Data as of March 10, 2021
- Data as of March 3, 2021
- Data as of February 24, 2021
- Data as of February 11, 2021
Chicago CCVI helps identify Chicago communities that have been disproportionately impacted by COVID-19 and are uniquely vulnerable to barriers to COVID-19 vaccine uptake for focused intervention.
Represents the total federal allocation to jurisdictions, including first and second doses.
The quantity of doses approved through valid orders in VTrckS and transmitted by the US Government to a distributor for fulfillment.
The number of vaccine doses that have been delivered to a provider’s location.
The number of vaccine doses that have been administered and reported into I-CARE.
Includes does jurisdictions have elected to transfer to pharmacies or other jurisdictions.